Innovax ND-ILT launched in the US

Merck Animal Health has now launched Innovax ND-ILT in the US, a single injection vaccine that provides protection against the highly infectious Newcastle disease (ND), infectious laryngotracheitis (ILT) and Marek’s disease when given to chickens either in ovo or subcutaneously at the hatchery. The vaccine is a frozen, cell associated, live virus vaccine that contains the serotype 3 HVT with the F gene from ND virus and two genes from ILT.
Ivan Alvarado, director, Poultry Technical Services, Merck Animal Health, said: “Along with the convenience of a single immunization, Innovax ND-ILT eliminates the risks of viral latency, persistence and dissemination associated with the use of conventional live vaccines. By controlling Newcastle disease and infectious laryngotracheitis, Innovax ND-ILT allows the administration of monovalent (infectious bronchitis virus) vaccines, avoiding competition between respiratory viruses while improving protection against (infectious bronchitis) in the field. As a recombinant HVT vaccine, Innovax ND-ILT does not induce post-vaccinal reactions, reversion to virulence or interference with other respiratory vaccines.”